Crescent Biopharma, Inc.

Crescent Biopharma, Inc. operates as a biotechnology company dedicated to advancing novel precision-engineered molecules targeting validated biology to advance care for patients with solid tumors. The company was incorporated in 2024 and is based in USA. Show More...

  • Website https://www.crescentbiopharma.com/
  • Sector Healthcare
  • Industry Biotechnology
  • Last Quote 12.80 USD
  • Last Updated 14-07-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD 37.8 -28.35 -22.05 -145.95 -101.85 -49.99 -21.75 -7.45 -2.68 -4.6 -3.62
    Dividends USD
    Payout Ratio % *
    Shares Mil 1.0 3.0 11.0 12.0 13.0
    Book Value Per Share * USD 334.04 572.48 549.49 456.93 350.82 47.51 24.45 4.09 10.87 6.75 5.59
    Free Cash Flow Per Share * USD 470.1 -269.4 -202.53 -129.07 -132.54 -93.48 -23.98 -7.54 -2.78 -3.74
    Return on Assets % 3.74 -3.27 -3.13 -27.85 -25.3 -16.26 -31.49 -65.75 -36.56 -49.38 -39.7
    Financial Leverage (Average) 2.86 1.48 1.08 1.08 1.03 2.21 2.37 1.28 1.04 1.44 1.13
    Return on Equity % 13.55 -6.41 -4.0 -30.08 -26.77 -21.01 -71.35 -108.92 -39.88 -58.61 -43.42
    Return on Invested Capital % 11.85 -7.15 -4.49 -30.08 -27.07 -13.27 -33.67 -71.53 -42.84 -59.75 -44.41
    Interest Coverage 95.28 -63.61 -81.55 -880.09 -8.99
    Current Ratio 2.21 2.53 11.26 8.53 37.11 1.82 1.71 4.48 25.83 3.32 9.13
    Quick Ratio 2.18 2.48 11.13 8.43 36.9 0.87 0.78 3.72 25.02 3.18 8.93
    Debt/Equity 0.010 0.010 0.010 0.02 0.010